Simultaneous Monitoring by Real-Time Polymerase Chain Reaction of Epstein-Barr Virus, Human Cytomegalovirus, and Human Herpesvirus-6 in Juvenile and Adult Liver Transplant Recipients

Transplantation Proceedings

Volumn 40, Issue 10, 2008, Pages 3578-3582

  Ono, Y ^a   Ito, Y ^a   Kaneko, K ^a   Shibata Watanabe, Y ^a   Tainaka, T ^a   Sumida, W ^a   Nakamura, T ^a   Kamei, H ^a   Kiuchi, T ^a   Ando, H ^a   Kimura, H ^a  

^a NAGOYA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

PREDNISOLONE; TACROLIMUS; VIRUS DNA;

ACUTE GRAFT REJECTION; ADOLESCENT; ADULT; ARTICLE; BLOOD ANALYSIS; BLOOD SAMPLING; CHILD; CLINICAL ARTICLE; CONTROLLED STUDY; CYTOMEGALOVIRUS INFECTION; EPSTEIN BARR VIRUS; FEMALE; GRAFT RECIPIENT; HERPES VIRUS INFECTION; HUMAN; HUMAN CYTOMEGALOVIRUS; HUMAN HERPESVIRUS 6; HUMAN TISSUE; IMMUNOSUPPRESSIVE TREATMENT; INFANT; JUVENILE; LIVER GRAFT; LIVER GRAFT REJECTION; LIVING DONOR; MALE; PERIPHERAL BLOOD MONONUCLEAR CELL; POSTOPERATIVE PERIOD; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SEROLOGY; VIREMIA; VIRUS LOAD;

ADOLESCENT; ADULT; CHILD; CYTOMEGALOVIRUS; CYTOMEGALOVIRUS INFECTIONS; DNA, VIRAL; EPSTEIN-BARR VIRUS INFECTIONS; FEMALE; HERPESVIRUS 4, HUMAN; HERPESVIRUS 6, HUMAN; HUMANS; LIVER TRANSPLANTATION; LIVING DONORS; MALE; POLYMERASE CHAIN REACTION; POSTOPERATIVE COMPLICATIONS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; ROSEOLOVIRUS INFECTIONS;

EID: 57549112036     PISSN: 00411345     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.transproceed.2008.05.082     Document Type: Article

References (24)

1. Kusne S., and Blair J.E. Viral and fungal infections after liver transplantation-part II. Liver Transpl 12 (2006) 2
2. Paya C.V., and Raymund R.R. Cytomegalovirus infection after solid organ transplantation. In: Bowden R.A., Ljungman P., and Paya C.V. (Eds). Transplant Infections (2003), Lippincott Williams & Wilkins, Philadelphia 298
3. Fishman J.A., Emery V., Freeman R., et al. Cytomegalovirus in transplantation-challenging the status quo. Clin Transplant 21 (2007) 149
4. Manez R., Breinig M.C., Linden P., et al. Posttransplant lymphoproliferative disease in primary Epstein-Barr virus infection after liver transplantation: the role of cytomegalovirus disease. J Infect Dis 176 (1997) 1462
5. Mendez J.C., Dockrell D.H., Espy M.J., et al. Human beta-herpesvirus interactions in solid organ transplant recipients. J Infect Dis 183 (2001) 179
6. Harma M., Loginov R., Piiparinen H., et al. HHV-6-DNAemia related to CMV-DNAemia after liver transplantation. Transplant Proc 37 (2005) 1230
7. Preiksaitis J.K., and Cockfield S.M. Epstein-Barr virus infection and lymphoproliferative disease after hemopoietic stem cell or solid organ transplantation. In: Bowden R.A., Ljungman P., and Paya C.V. (Eds). Transplant Infections (2003), Lippincott Williams & Wilkins, Philadelphia 298
8. Ho M., Jaffe R., Miller G., et al. The frequency of Epstein-Barr virus infection and associated lymphoproliferative syndrome after transplantation and its manifestations in children. Transplantation 45 (1988) 719
9. Baldanti F., Grossi P., Furione M., et al. High levels of Epstein-Barr virus DNA in blood of solid-organ transplant recipients and their value in predicting posttransplant lymphoproliferative disorders. J Clin Microbiol 38 (2000) 613
10. Orii T., Ohkohchi N., Kikuchi H., et al. Usefulness of quantitative real-time polymerase chain reaction in following up patients with Epstein-Barr virus infection after liver transplantation. Clin Transplant 14 (2000) 308
11. Orii T., Ohkohchi N., Satomi S., et al. Decreasing the Epstein-Barr virus load by adjusting the FK506 blood level. Transpl Int 15 (2002) 529
12. Hoshino K., Nishi T., Adachi H., et al. Human herpesvirus-6 infection in renal allografts: retrospective immunohistochemical study in Japanese recipients. Transpl Int 8 (1995) 169
13. Humar A., Kumar D., Caliendo A.M., et al. Clinical impact of human herpesvirus 6 infection after liver transplantation. Transplantation 73 (2002) 599
14. Yoshikawa T. Human herpesvirus-6 and -7 infections in transplantation. Pediatr Transplant 7 (2003) 11
15. Loginov R., Harma M., Halme L., et al. HHV-6 DNA in peripheral blood mononuclear cells after liver transplantation. J Clin Virol 37 suppl 1 (2006) S76
16. Ohashi M., Sugata K., Ihira M., et al. Human herpesvirus 6 infection in adult living related liver transplant recipients. Liver Transpl 14 (2008) 100
17. Kamei H., Fujimoto Y., Nagai S., et al. Impact of non-congestive graft size in living donor liver transplantation: new indicator for additional vein reconstruction in right liver graft. Liver Transpl 13 (2007) 1295
18. Kimura H., Morita M., Yabuta Y., et al. Quantitative analysis of Epstein-Barr virus load by using a real-time PCR assay. J Clin Microbiol 37 (1999) 132
19. Tanaka N., Kimura H., Hoshino Y., et al. Monitoring four herpesviruses in unrelated cord blood transplantation. Bone Marrow Transplant 26 (2000) 1193
20. Tanaka N., Kimura H., Iida K., et al. Quantitative analysis of cytomegalovirus load using a real-time PCR assay. J Med Virol 60 (2000) 455
21. Preiksaitis J.K., Sandhu J., and Strautman M. The risk of transfusion-acquired CMV infection in seronegative solid-organ transplant recipients receiving non-WBC-reduced blood components not screened for CMV antibody (1984 to 1996): experience at a single Canadian center. Transfusion 42 (2002) 396
22. Pouteil-Noble C., Ecochard R., Landrivon G., et al. Cytomegalovirus infection-an etiological factor for rejection?. A prospective study in 242 renal transplant patients. Transplantation 55 (1993) 851
23. Reinke P., Fietze E., Ode-Hakim S., et al. Late-acute renal allograft rejection and symptomless cytomegalovirus infection. Lancet 344 (1994) 1737
24. Lautenschlager I., Hockerstedt K., Linnavuori K., et al. Human herpesvirus-6 infection after liver transplantation. Clin Infect Dis 26 (1998) 702